Skip to content

The effectiveness of a targeted diabetes prevention programme for Hindustani Surinamese, consisting of screening followed by a lifestyle intervention

The effectiveness of a targeted diabetes prevention programme for Hindustani Surinamese, consisting of screening followed by a lifestyle intervention - Diabetes intervention study in Hindustani Surinamese (DHIAAN)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON33936
Enrollment
6000
Registered
2009-06-02
Start date
2009-01-15
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus high blood sugar prediabetes

Interventions

The lifestyle intervention consists of 6-8 sessions of individual dietary counselling based on motivational interviewing, supplemented with 1-2 home visits, and 2 optional group sessions aimed at th

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria Screening: - Hindustani Surinamese background - Aged between 18-60 years;Inclusion criteria Intervention: - Hindustani Surinamese background - Aged between 18-60 years - Persons found to have prediabetes during the screening (see protocol for definition)

Exclusion criteria

Exclusion criteria: Exclusion criteria screening: - Previous diagnosis of diabetes mellitus - Current pregnancy (these women can participate after giving birth);Exclusion criteria intervention: - Persons found to have diabetes mellitus during the screening - Any chronic illness that makes participation in a lifestyle-intervention impossible - Pregnancy - Medication known to interfere with glucose tolerance - Participation in a regular vigorous exercise and/or diet program

Design outcomes

Primary

MeasureTime frame
For the screening the primary outcome is the prevalence of prediabetes and DM and the incidence of DM (after 3 years). The primary outcome of the trial is the incidence of diabetes mellitus as determined by the oral glucose tolerance test.

Secondary

MeasureTime frame
Secondary or intermediate outcomes of the trial include, for example, motivational factors, diet, physical activity, plasma glucose levels, blood pressure levels, lipid profile, microalbuminuria, heart rate and weight and cost.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)